Matches in Wikidata for { <http://www.wikidata.org/entity/Q64042451> ?p ?o ?g. }
Showing items 1 to 26 of
26
with 100 items per page.
- Q64042451 description "clinical trial" @default.
- Q64042451 description "ensayu clínicu" @default.
- Q64042451 description "klinisch onderzoek" @default.
- Q64042451 description "клінічне випробування" @default.
- Q64042451 name "Comparison of 4.0 mg/kg Sugammadex at 1-2 Post Tetanic Counts (PTC) in Renal or Control Patients (19.4.328)(P05769)" @default.
- Q64042451 type Item @default.
- Q64042451 label "Comparison of 4.0 mg/kg Sugammadex at 1-2 Post Tetanic Counts (PTC) in Renal or Control Patients (19.4.328)(P05769)" @default.
- Q64042451 prefLabel "Comparison of 4.0 mg/kg Sugammadex at 1-2 Post Tetanic Counts (PTC) in Renal or Control Patients (19.4.328)(P05769)" @default.
- Q64042451 P1132 Q64042451-F84DCE27-D9A3-4997-8BA0-82B8FEEC2367 @default.
- Q64042451 P1476 Q64042451-FDE99F94-FCD2-486E-974C-7F46E0C6B993 @default.
- Q64042451 P2899 Q64042451-80A41EE4-4CA7-443B-ADBA-3879CBC047D2 @default.
- Q64042451 P3098 Q64042451-CBD2D9D7-38BF-4531-A6E1-11EC3EF90F4F @default.
- Q64042451 P31 Q64042451-8BB5C4AF-A757-49F6-82D5-8082E9F1CEB6 @default.
- Q64042451 P580 Q64042451-68BB57A9-9598-4892-81B2-60753B198AFA @default.
- Q64042451 P582 Q64042451-3D0BD767-711A-417B-9B80-309929B23759 @default.
- Q64042451 P6099 Q64042451-9D3D3C2F-0A50-4A64-9E10-FA7A8C52A91A @default.
- Q64042451 P8363 Q64042451-7F00EC69-922D-4B10-B9AA-6AD976CB6274 @default.
- Q64042451 P1132 "+69" @default.
- Q64042451 P1476 "A Multi-center, Parallel-group, Comparative Trial Evaluating the Efficacy, Pharmacokinetics and Safety of 4.0 mg/kg Sugammadex Administered at 1-2 PTC in Subjects With Normal or Severely Impaired Renal Function" @default.
- Q64042451 P2899 "+18" @default.
- Q64042451 P3098 "NCT00702715" @default.
- Q64042451 P31 Q30612 @default.
- Q64042451 P580 "2008-09-24T00:00:00Z" @default.
- Q64042451 P582 "2010-03-15T00:00:00Z" @default.
- Q64042451 P6099 Q42824827 @default.
- Q64042451 P8363 Q78089383 @default.